SCO­TUS rais­es ques­tions over le­gal stand­ing in abor­tion pill case

WASH­ING­TON, DC – Supreme Court jus­tices ap­peared un­cer­tain on Tues­day that doc­tors and an­ti-abor­tion groups have stand­ing to chal­lenge the FDA’s cur­rent la­bel for the com­mon­ly used abor­tion pill mifepri­s­tone.

The Court is tasked with de­cid­ing whether to up­hold a Fifth Cir­cuit de­ci­sion re­vers­ing the FDA’s long-stand­ing pre­scrib­ing con­di­tions for mifepri­s­tone. While the drug has been ap­proved in the US for more than two decades, key la­bel changes in 2016 and 2021 have al­lowed the pill to be dis­trib­uted by mail and ex­tend­ed how late in­to preg­nan­cy it can be tak­en by three weeks.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.